Signaturefd, LLC Stoke Therapeutics, Inc. Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$7.93 - $13.82 $39 - $69	5 Added 0.49%	1,031 $10,000
Q1 2023 Apr 28, 2023	BUY	$7.65 - $10.38 $3,503 - $4,754	458 Added 80.63%	1,026 $8,000
Q4 2022 Jan 27, 2023	BUY	$7.07 - $15.69 $3,188 - $7,076	451 Added 385.47%	568 $5,000
Q2 2022 Aug 10, 2022	SELL	$10.36 - $23.93 $4,610 - $10,648	-445 Reduced 79.18%	117 $2,000
Q1 2022 May 02, 2022	BUY	$17.19 - $26.1 $9,660 - $14,668	562 New	562 $12,000
Q4 2021 Jan 25, 2022	SELL	$18.11 - $30.72 $597 - $1,013	-33 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$23.65 - $34.44 $780 - $1,136	33 New	33 $1,000

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $367M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.